Eighth Symposium on COVID-19: What Have We Learned? How Can We Use What We Have Learned?

December 3, 2020 3:00pm – 4:30pm ET
Add to Calendar
12/3/20 3:00 PM 12/3/20 4:30 PM Eighth Symposium on COVID-19: What Have We Learned? How Can We Use What We Have Learned? Online via Zoom Eighth Symposium on COVID-19: What Have We Learned? How Can We Use What We Have Learned?
Online via Zoom

Kadish and Halperin

An online webinar, the eighth Coronavirus (COVID-19) Symposium is sponsored by New York Medical College of the Touro College and University System. Continuing Education credits are available upon request.

A presentation by the Center for Disaster Medicine of New York Medical College of the Touro College and University System.

Program

Introduction and Welcome:

Alan Kadish, M.D.
Cardiologist | President, Touro College and University System | President, New York Medical College

Opening Remarks:

Edward C. Halperin, M.D., M.A.
Chancellor and CEO, Professor of Radiation Oncology, Pediatrics and History, New York Medical College | Provost for Biomedical Affairs, Touro College and University System

Can the Family Get Together for Christmas / Hanukkah / Kwanza / New Year's?

by Robert Amler, M.D., MBA
Dean, School of Health Sciences and Practice, Vice President for Government Affairs, New York Medical College | Former Regional Health Administrator, U.S. Department of Health and Human Services | Former Medical Epidemiologist, Centers for Disease Control and Prevention (CDC)

What Are the Limits of Authority of a Public Health Commissioner in this Crisis?

by Sherlita Amler, M.D., M.S., FAAP
Commissioner of Health, Westchester County, NY

A Potential Preventative Nasal Spray for COVID-19?

by Mill Etienne, M.D., M.P.H., FAAN, FAES
Associate Dean for Student Affairs, Associate Professor of Neurology, School of Medicine House Advisory Dean, New York Medical College

An Update on Vaccine Development and Deployment

by Kathleen DiCaprio, Ph.D.
Assistant Professor of Medical Microbiology and Immunology, Touro College of Osteopathic Medicine

Childhood Development Issues in a Pandemic

by Tami Hendriksz, DO
Professor and Associate Dean of Academic Affairs, Touro University California College of Osteopathic Medicine

Are We on the Verge of Having Millions of Americans With a New "Pre-Existing Condition"?

by Marisa A. Montecalvo, M.D.
Medical Director, Health Services, Professor of Medicine, New York Medical College | Infectious Disease Specialist

They Said Hydroxycholoroquine Wasn't Useful in COVID-19 and Remdesivir is - Now They're Saying the Opposite. What Should We Believe?

by Neil Schluger, M.D.
Barbara and William Rosenthal Chair of the Department of Medicine, School of Medicine, New York Medical College | Director of Medicine, Westchester Medical Center

MODERATOR:

by Edward C. Halperin, M.D., M.A.
Chancellor and CEO, New York Medical College | Provost for Biomedical Affairs, Touro College and University System

Q&A:

Hosted by Alan Kadish, M.D.
Cardiologist | President, Touro College and University System | President, New York Medical College

 

Responses will be provided to the questions submitted in advance of the webinar. Questions may be submitted to covid19updates@touro.edu

Register in advance for this webinar

 

This meeting has been approved for 1.5 CME credits by the Office of Continuing Medical Education, New York Medical College free of charge as a community service to our Healthcare Providers.

Accreditation Statement: New York Medical College is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

New York Medical College designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support: There is no outside funding for this activity.

Disclosures: All activity faculty and planners participating in continuing medical education activities provided by New York Medical College are expected to disclose to the audience any significant support or substantial relationship(s) with commercial entities whose products are discussed in their presentation and/or with any commercial supporters of the activity.